D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced it has achieved “Awardable” status in the US Department of Defense’s (DoD) Tradewinds Solutions Marketplace, which showcases cutting-edge technologies for potential DoD adoption. This designation endorses D-Wave’s annealing quantum…
Annovis (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), presented two scientific posters at the 17th Clinical Trials on Alzheimer’s…
President Biden has rolled out a new plan aimed at enabling the U.S. to harness AI for national security purposes amid a global race that is seeing different countries scrambling to tap this new technology…
CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This…
SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq’s listing standards, meeting minimum bid price, public float, and stockholders’ equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe’s common stock will…